IMC Chicago LLC reduced its stake in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) by 89.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,558 shares of the company’s stock after selling 13,087 shares during the period. IMC Chicago LLC owned 0.06% of Direxion Daily S&P Biotech Bull 3x Shares worth $259,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Squarepoint Ops LLC boosted its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock worth $9,171,000 after purchasing an additional 40,157 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Direxion Daily S&P Biotech Bull 3x Shares by 664.7% in the 3rd quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock valued at $5,445,000 after buying an additional 50,564 shares in the last quarter. JPMorgan Chase & Co. acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth approximately $3,208,000. Renaissance Technologies LLC raised its stake in Direxion Daily S&P Biotech Bull 3x Shares by 10.6% during the 4th quarter. Renaissance Technologies LLC now owns 22,900 shares of the company’s stock worth $3,650,000 after buying an additional 2,200 shares during the period. Finally, Virtu Financial LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter worth approximately $1,757,000.
Direxion Daily S&P Biotech Bull 3x Shares Trading Down 8.2%
Shares of NYSEARCA:LABU opened at $254.80 on Friday. Direxion Daily S&P Biotech Bull 3x Shares has a 52-week low of $58.35 and a 52-week high of $333.00. The business’s 50 day simple moving average is $218.82 and its two-hundred day simple moving average is $187.08.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Articles
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Want to see what other hedge funds are holding LABU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report).
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
